Amazon

DMARC

Amazon S3 CDN

Cris De Luca

Partner, Digital Investments, Sanofi Ventures

Jason P. Hafler

Managing Director

Laia Crespo

Head of Investments - Sanofi Ventures

Frederic Turner

Senior Vice President

Alba Zurriaga Carda

Director of Investments

Charles Thyne

Industrial Operations

Bernard Davitian

Vice President and Managing Director

Megan Krench

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

Inozyme  is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

Seed Stage Investors with Investments in Newton, Massachusetts

Post IPO Investors with Investments in Greater Boston Area

Venture Stage Investors with Investments in West Coast

Corporate VC Investors with Investments in Asia

Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.

Sanofi Ventures Evergreen Fund

Cambridge

Massachusetts

United States

North America

Sanofi Ventures

France

Europe

Hong Kong

Asia

India

Ascension Ventures

Catalyst by Wellstar

MS Ventures

Regeneron Pharmaceuticals

Galectin Therapeutics

Kurma Partners

Sanofi Ventures is the corporate venture capital arm of Sanofi, a global biopharmaceutical company. It focuses on investing in innovative startups and companies that are developing transformative therapies and technologies across various stages of development. The firm seeks to build a portfolio that aligns with Sanofi's strategic interests and leverages the parent company's expertise to support the growth of its investments.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 11, 2024 4:55 AM	07950a1f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	a335c5dc
crunchbase profile	general	Nov 25, 2024 11:38 AM	7ac57703
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:09 PM	7f02a937
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

SANO

COM:SANOFIVENTURES

Sanofi Ventures